There are 2867 resources available
Summary and close
Presenter: Thomas Powles
Session: Janssen-Cilag International NV - Catching it early, getting it right: optimal disease and patient management from biomarkers to treatment selection for bladder cancer
Resources:
Webcast
Conclusion
Presenter: Allan Hackshaw
Session: F. Hoffman-La Roche LTD - Navigating the possibilities of personalised healthcare in oncology
Resources:
Webcast
519MO - Phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial of cemiplimab in recurrent or metastatic (R/M) cervical cancer: Long-term survival analysis
Presenter: Ana Oaknin
Session: Mini Oral session 1: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
LBA34 - Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
Presenter: Richard Finn
Session: Proffered Paper session 1: GI, upper digestive
Resources:
Abstract
Slides
Webcast
Introduction and scientific background
Presenter: Fiona Blackhall
Session: Current and future perspectives in SCLC
Resources:
Slides
Webcast
Welcome to EONS15 the conference
Presenter: Johan De Munter
Session: Welcome to the EONS15 conference
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Eva Ciruelos
Session: Antibody-drug conjugates to transform outcome of patients with metastatic breast cancer
Resources:
Slides
Webcast
Pro: Tumor mutional burden as a tumor agnostic biomarker?
Presenter: Aurélien Marabelle
Session: Young Oncologist Boxing session
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Sergio Quezada
Session: Progress in the identification of new immune targets
Resources:
Slides
Webcast
LBA35 - Camrelizumab (C) plus rivoceranib (R) vs. sorafenib (S) as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A randomized, phase III trial
Presenter: Shukui Qin
Session: Proffered Paper session 1: GI, upper digestive
Resources:
Abstract
Slides
Webcast